Tag Archive for: STTR

UPDATE: Congress on Track to Reauthorize the SBIR and STTR Programs

SBIR/STTR programs will expire if Congress doesn’t reauthorize by September 30th. Senator Paul blocked reauthorization because of security problems. New provisions added to address security concerns.
Bill passed Senate, expected to pass House. SBIR/STTR programs extended for three more years.

Read more
/0 Comments/by

SBIR/STTR Programs Could Expire Sept. 30

SBIR/STTR programs could expire Sept 30. Reauthorization opposed by Rand Paul and others. SBIR/STTR grants enable commercialization of federally funded research and have broad benefits that improve life for all Americans as well as billions around the globe.

Read more
/0 Comments/by

NDFS17 Video: NCI Funding & Commercialization Resources for Cancer Tech

Dr. William Bozza discusses non-dilutive funding opportunities at NCI and NIH.

Read more
/0 Comments/by

NDFS17 Video: NINDS Funding Programs for Translational Research in Neuroscience

Dr. Charles L. Cywin discusses non-dilutive funding opportunities at NINDS and NIH.

Read more
/0 Comments/by

NDFS17 Video: The NIDDK SBIR Program: An Overview

Dr. Daniel Gossett discusses non-dilutive funding opportunities at NIDDK and NIH.

Read more
/0 Comments/by

NDFS17 Video: CIRM Translation & Clinical Development Grants for Cell & Gene Therapy

Dr. Abla Creasey discusses non-dilutive funding opportunities at the California Institute for Regenerative Medicine, which funds stem cell R&D.

Read more
/0 Comments/by